Ifosfamide and the leaking tubule
Why it happens
That is the Fanconi syndrome. Magnesium is lost too. The glomerular filtration rate can stay normal, so the creatinine does not warn you. Cyclophosphamide, the sister drug, makes little of this metabolite and almost never does this. Mesna protects the bladder, not the tubule. The same metabolite causes ifosfamide encephalopathy.
Recognize it on the morning labs
Low bicarbonate with a normal anion gap.
Low uric acid (the opposite of tumor lysis).
Creatinine often normal.
Phosphate and magnesium still being excreted despite low blood levels: fractional excretion of phosphate above 5% when the serum phosphate is low (or a low TmP/GFR).
Urine pH is usually acid (below 5.5) once the serum bicarbonate has fallen; it turns alkaline when you give bicarbonate, because the tubule spills it. A low urine pH does not exclude this.
Prior cisplatin, a single or damaged kidney, young age in some series.
Can appear during the course or months after it.
In adults the full syndrome is uncommon; partial tubular wasting is not.In a prospective cohort of children and young adults with sarcoma on high-dose ifosfamide, 4% developed a Fanconi-like syndrome, but every patient had a measurable, reversible tubular leak after each cycle (Ho 1995). Adult series are smaller and the full syndrome is uncommon; partial wasting is the rule. In children, moderate or severe nephrotoxicity is reported in about 28% (Skinner 2000), with rickets in the severe cases.
Replace in this order
Alkali raises the pH, more calcium binds to albumin, and the free (ionized) fraction drops. The same reason hyperventilating patients get tingling. The cue: Mag, then K and phos, then calcium, alkali last.
Next steps
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Skinner R, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996. doi:10.1016/s0140-6736(96)03480-0
- Skinner R, Cotterill SJ, Stevens MC. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer 2000. doi:10.1054/bjoc.2000.1214
- Ho PT, et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer 1995.doi:10.1002/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9
- Hanly L, et al. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Expert Opin Drug Saf 2009. doi:10.1517/14740330902808169
- Quiroz-Aldave JE, et al. Ifosfamide-induced nephrotoxicity in oncological patients. Expert Rev Anticancer Ther 2024. doi:10.1080/14737140.2023.2290196
Visceral crisis: what it is, and what it is not
The definition
From the ESO-ESMO international consensus for advanced breast cancer (ABC). The concept was written to decide chemotherapy against endocrine therapy in breast cancer, and is borrowed by analogy for other tumors.
Crisis or not?
Lung: dyspnea at rest, worsening fast, not fixed by draining an effusion.
Marrow: severe cytopenias from infiltration.
Meninges: symptomatic leptomeningeal disease.
Liver and lung are the consensus examples; marrow and meninges are the categories used in the Chinese series below (Yang 2022).
Lung nodules without symptoms.
A large mass that is not failing an organ.
These are "high burden". High burden with working organs is not a crisis and not an impending one; the slower option can still be the right one.
Impending visceral crisis: the criteria are not met yet but failure is foreseeable without fast treatment.The ABC 5 example is more than 70% of the liver replaced, enzymes substantially up, bilirubin still normal. The consensus recommends the most rapidly effective therapy here too. Püsküllüoğlu 2024 operationalized it as transaminases above twice normal with rising LDH, alkaline phosphatase or GGT.
Why the word matters: the trial that tested it
Two details decide the lesson. The trial excluded a bilirubin above 1.5 times normal, so no patient met the consensus liver criterion, and in the half the investigators still labeled "visceral crisis", progression-free survival was similar in the two arms. The overall win belongs to the patients who looked aggressive but were not failing an organ. The true crisis is the patient who cannot wait the extra month and a half for a response, and that is a bedside judgment, not a scan.
How bad is a true crisis?
At the bedside
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Cardoso F, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 2020. doi:10.1016/j.annonc.2020.09.010
- Lu YS, et al. Final results of RIGHT Choice: ribociclib plus endocrine therapy versus combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2- advanced breast cancer. J Clin Oncol 2024. doi:10.1200/JCO.24.00144
- Yang R, et al. Different treatment regimens in breast cancer visceral crisis: a retrospective cohort study. Front Oncol 2022. doi:10.3389/fonc.2022.1048781
- Püsküllüoğlu M, et al. Cisplatin monotherapy for HER-2 negative breast cancer with hepatic visceral crisis or impending visceral crisis. Oncol Ther 2024. doi:10.1007/s40487-024-00280-9
Cryoglobulins: think of them, then send them warm
What they are
Myeloma, Waldenström, MGUS.
Clogs rather than inflames: thick blood, cold fingers, ulcers, retinal changes.
Hepatitis C, B-cell lymphomas, Sjögren, and the B-cell expansion of AITL.
Vasculitis.
Autoimmune disease, chronic infections, lymphomas.
Vasculitis, usually milder.
Types II and III are called mixed cryoglobulinemia. The classic triad of mixed disease: palpable purpura, joint pain, weakness. Add neuropathy (painful, asymmetric, legs first) and a glomerulonephritis with blood and protein in the urine.
Why angioimmunoblastic T-cell lymphoma
The malignant cell is a T follicular helper cell: its job in a normal lymph node is to make B cells produce antibodies. The lymphoma keeps doing that job.So patients have polyclonal hypergammaglobulinemia, a positive direct Coombs test with hemolysis, autoantibodies, rash, effusions, and sometimes cryoglobulins. Epstein-Barr virus-positive B cells expand alongside the tumor. The immune picture can arrive months before the lymphoma is diagnosed, and the first doctor is often a rheumatologist or a nephrologist (Li 2020; Lunning and Vose 2017).
Cryoglobulinemic vasculitis (painful, asymmetric, with purpura).
Paraneoplastic or direct nerve infiltration (rare).
When to send it
How to send it
In a European survey of 137 laboratories only about a third kept the sample at 37 °C until the serum was separated (Vermeersch 2008); the reviewers' verdict was that false negatives from a cooled sample are the commonest error (Sargur 2010).In the case report above the first serum cryoglobulin was negative; the biopsy made the diagnosis. Even a small cryoprecipitate can cause severe symptoms, so a "trace" result is not a negative result. Call the lab before drawing: many give a warmed container or ask for the draw in the lab itself. The answer takes days, so send it early.
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Sargur R, White P, Egner W. Cryoglobulin evaluation: best practice? Ann Clin Biochem 2010. doi:10.1258/acb.2009.009180
- Vermeersch P, et al. A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins. Clin Chem 2008. doi:10.1373/clinchem.2007.090134
- Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood 2017. doi:10.1182/blood-2016-09-692541
- Li XY, et al. Delayed diagnosis of angioimmunoblastic T-cell lymphoma presenting with type II cryoglobulinemia and acute kidney injury: case report and narrative review. BMC Nephrol 2020. doi:10.1186/s12882-020-02125-9
The confused myeloma patient
Why light chains do not cause hyperviscosity
IgA, which polymerizes: usually above 6 g/dL.
IgG: rarely below 6 to 10 g/dL, except IgG3, which aggregates at lower levels.
They damage the kidney instead (cast nephropathy), which is what light-chain myeloma does to the patient.
Serum viscosity above 4 centipoise usually means symptoms; normal is 1.4 to 1.8.Stone and Bogen 2012. Clues: nosebleeds or gum bleeding, blurred vision, headache, confusion, and on fundoscopy dilated, sausage-shaped retinal veins with flame hemorrhages. Fundoscopy is the fastest test on the ward. Treatment is plasma exchange (one or two sessions usually relieve symptoms, because most of the IgM sits in the plasma) plus therapy for the clone.
Work through the list, in order
Infection
Myeloma, steroids and a dialysis catheter. New fever, rising white count with toxic granulation: blood cultures from the line and a vein, empiric antibiotics, then think. Steroids blunt the fever and raise the white count on their own, so culture anyway.
Metabolic
Calcium (corrected for albumin, or ionized), sodium, glucose on dexamethasone, uremia or a missed dialysis session.
Drugs on a failing kidney
High-dose dexamethasone delirium. Opioids: morphine, codeine and hydrocodone have active metabolites that accumulate without a kidney. Fentanyl (and methadone or buprenorphine) are the safe choices; hydromorphone is acceptable at reduced dose and interval, its glucuronide accumulates too. Gabapentin and pregabalin accumulate too.
Brain
Stroke or bleed with low platelets: CT head without contrast. Posterior reversible encephalopathy with hypertension. Myeloma in the skull base or meninges is rare.
Hyperviscosity
Only with a large IgM, IgA or IgG spike, as above. Fundoscopy now. Send serum viscosity, but do not wait for it: symptoms plus a large spike is enough to call apheresis. Do not transfuse red cells for the anemia before the exchange; it raises the viscosity.
Plasma exchange: two different questions
A French trial that removed light chains by high-cutoff dialysis during bortezomib (MYRE 2017) also missed its 3-month endpoint; what the kidney needs is the clone to collapse fast.
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood 2012. doi:10.1182/blood-2011-04-347690
- Bey T, Qdaisat A. Hyperviscosity syndrome: an oncologic emergency. Emerg Med Clin North Am 2025. doi:10.1016/j.emc.2025.03.001
- Clark WF, et al. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005. doi:10.7326/0003-4819-143-11-200512060-00005
- Bridoux F, et al. Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy (MYRE). JAMA 2017. doi:10.1001/jama.2017.17924
- See also the myeloma kidney page of Oct 9.